With biometrics core to our business, we are proud to have developed and maintained FSP strategic relationships over the years.
The FSP models we already have in place include:
- Biometric strategic partners for the early phase (translational medicine)
- Biometric preferred providers for early phase oncology adaptive trials
- Biometric preferred provider for Phase IV trials